Related Experiment Videos
Biliary lithotripsy with a new electromagnetic shock wave source. A 2-year clinical experience
T Wehrmann1, A Hurst, B Lembcke
1Department of Internal Medicine, University Hospital, Frankfurt/Main, Germany.
Digestive Diseases and Sciences
|November 1, 1993
Summary
A new electromagnetic lithotriptor (Modulith) safely and effectively treated gallbladder stones in 170 patients. High fragmentation rates and minimal side effects were observed, with many patients stone-free after one year.
Area of Science:
- Gastroenterology and Hepatology
- Medical Devices and Technology
- Endourology
Background:
- Gallbladder stones (cholelithiasis) pose a significant clinical challenge.
- Existing lithotripsy methods have limitations in efficacy and patient comfort.
- The Modulith electromagnetic lithotriptor represents a novel approach to stone fragmentation.
Purpose of the Study:
- To evaluate the safety and efficacy of the Modulith electromagnetic lithotriptor for treating gallbladder stones.
- To assess the effectiveness of Modulith lithotripsy in an outpatient setting.
- To determine the long-term stone-free rates after treatment.
Main Methods:
- A prospective study involving 170 consecutive patients with gallbladder stones.
- Treatment with the Modulith electromagnetic lithotriptor and oral bile acids.
- Assessment of fragmentation success, side effects, and stone-free status at 12 months.
Main Results:
- Sufficient fragmentation achieved in 94% of patients with gallbladder stones.
- High success rate (92%) in treating common bile duct stones using Modulith.
- Transient and mild side effects reported, with low incidence of biliary pancreatitis.
- 67% of patients were stone-free after one year, with higher rates for smaller stones.
Conclusions:
- The Modulith electromagnetic lithotriptor is a safe and highly effective tool for gallbladder stone lithotripsy.
- Outpatient treatment with Modulith demonstrates excellent outcomes and patient tolerance.
- Modulith lithotripsy offers a viable option for managing both gallbladder and common bile duct stones.